Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...
Arcturus Therapeutics: Q3 Earnings Snapshot
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Arcturus Therapeutics Holdings Inc. ARCT: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings...
Arcturus Therapeutics: Q2 Earnings Snapshot
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.32%. US stock indexes...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.39%. US stock indexes today are...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.07%. US stock indexes today are...
The company saw revenue decline and net losses rise in the second quarter.
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines...
Investors liked what they heard in its Q4 update.